Real-world use of abbreviated dual antiplatelet therapy after percutaneous coronary intervention among patients with high bleeding risk: Are guidelines followed? Insights from the FRANCE-PCI registry
Real-world use of abbreviated dual antiplatelet therapy after percutaneous coronary intervention among patients with high bleeding risk: Are guidelines followed? Insights from the FRANCE-PCI registry. // Archives of Cardiovascular Diseases. – URL: https://www.sciencedirect.com/science/article/pii/S1875213626002391?dgcid=rss_sd_all
Real-world use of abbreviated dual antiplatelet therapy after percutaneous coronary intervention among patients with high bleeding risk: Are guidelines followed? Insights from the FRANCE-PCI registry. Archives of Cardiovascular Diseases. https://www.sciencedirect.com/science/article/pii/S1875213626002391?dgcid=rss_sd_all
“Real-world use of abbreviated dual antiplatelet therapy after percutaneous coronary intervention among patients with high bleeding risk: Are guidelines followed? Insights from the FRANCE-PCI registry.” Archives of Cardiovascular Diseases.
@article{article88439,
title = {Real-world use of abbreviated dual antiplatelet therapy after percutaneous coronary intervention among patients with high bleeding risk: Are guidelines followed? Insights from the FRANCE-PCI registry},
journal = {Archives of Cardiovascular Diseases},
url = {https://www.sciencedirect.com/science/article/pii/S1875213626002391?dgcid=rss_sd_all}
}